Opportunities to be a corporate sponsor of the European Aniridia Conference are now open.
By sponsiring, your organisation can from push forward understanding of aniridia to prevent sight loss, improving the lives of thousands of patients around the world. You will:
- play a key role in finding effective treatments for aniridia
- raise your brand profile at the leading edge of global scientific research and medical arenas, plus with patients and relatives
- build valuable new connections with 250 influential individuals in the ophthalmology, genetics and aniridia communities.
All sponsors will be publicly recognised on this site, social media and other formats, plus get a range of benefits proportional to the level of their support:
Our sponsors
Your support is our light
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. | www.cost.eu
#CA18116 COST Action https://aniridia-net.eu/
TW: @AniridiaNet
Our collaborators and supporters
Your support is our light
The Rare Disease and Orphan Drugs Journal (RDODJ) is an international, peer-reviewed, open access journal for the publication of innovative research works on various aspects of this rapidly growing multidisciplinary and interdisciplinary field. RDODJ will report on scientific advances in the genetics of rare diseases, the molecular basis of the pathologies, and translational research on diagnosis, prevention and treatment.
